Refresh Contacts (which contains carboxymethylcellulose sodium) is commonly used in situations involving recurrent or episodic manifestations of ocular dryness.

Relief from Mild Ocular Dryness and Surface Irritation

The preparation is applied across domains where additional symptomatic support is needed to address symptom clusters that may become intense or disruptive, such as stinging and burning sensations. It generally contributes to easing the overall symptom load associated with mild irritation, and may assist with coping more steadily with symptom fluctuations.

Support for Friction and Foreign Body Sensations

This product is relevant in contexts marked by increased discomfort or tension, such as the gritty feeling or foreign body sensation in the eye. It supports the patient during difficult episodes by easing distress and assists with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities.

Managing Symptoms Related to Contact Lens and Environmental Stress

The medication is commonly used when short-term symptomatic assistance is needed in clinical scenarios where symptoms may intensify temporarily, such as due to prolonged screen time or environmental exposure (wind or sun). It is considered relevant for easing the challenging symptoms experienced by contact lens wearers, and helps improve day-to-day comfort during symptomatic periods.

---

Quick Fact: Relevant for Friction and Foreign Body Sensation

---

Regulatory References

1. National Library of Medicine’s DailyMed database

Who Can and Cannot Use Refresh Contacts?

This section details the official population eligibility and exclusion criteria for Refresh Contacts (Carboxymethylcellulose Sodium ophthalmic solution), as defined in government regulatory labeling.

---

Eligibility Status

Classification	Population/Condition
Allowed	Adults seeking relief from ocular irritation.
Allowed	Individuals wearing soft or rigid gas permeable (RGP) contact lenses.
Contraindicated	Individuals with known hypersensitivity to Carboxymethylcellulose Sodium or any other component in the drops.
Acceptable	Pregnant or breastfeeding individuals due to negligible systemic absorption of the active ingredient.

---

Regulatory Restrictions and Limitations

Regulatory documents stipulate that self-care use must be discontinued and a physician consulted if eye pain, changes in vision, or persistent redness or irritation occurs or worsens after 72 hours. This defines a conditional restriction on continued eligibility for unsupervised use.

Use is primarily documented for adults. Specific data establishing safety and efficacy for general pediatric use is not consistently detailed in the product’s Over-the-Counter (OTC) labeling.

Interactions with Other Medicines and Products

Refresh Contacts (Carmellose Sodium Ophthalmic Solution) has a highly limited interaction profile, which is confirmed by regulatory documentation. The active ingredient, Carmellose Sodium, functions as an ophthalmic demulcent with a physical, lubricating mechanism that results in negligible systemic absorption when applied to the eye. Consequently, the product does not participate in classic pharmacokinetic interactions.

Documented Interaction Profile

Interaction Type	Official Regulatory Statement
Systemic Pharmacokinetic	No documented interactions with oral or systemic medications, CYP enzymes, or drug transporters.
Food, Alcohol, Supplements	No documented interactions with food, alcohol, or herbal products.
Contraindicated Combinations	No medicinal products are formally classified as prohibited (contraindicated) for co-administration.

---

Timing-Based Interaction Restriction

The only officially documented concern is local pharmacodynamic interference at the eye's surface. The product creates a film that can potentially interfere with the absorption of other topical ophthalmic preparations, such as medicated drops or solutions.

To address this, regulatory guidance requires a timing separation when using the product with other eye medications. Specifically, if another eye drop or solution is administered concurrently, an official waiting period of at least 5 minutes is necessary between the applications. If an eye ointment is also used, the drops should be administered first.

How Refresh Contacts Works

Polymeric Lubrication and Viscoelastic Film Deposition

The function of this solution is purely biophysical, focused on the interaction with the surface of the contact lens and the adjacent aqueous film. The mechanism involves the physical binding of hydrophilic polymers to the contact lens material, which facilitates the formation of a localized, stable, viscoelastic layer. This polymeric deposition increases the lens’s overall surface wettability and decreases the coefficient of friction during the relative movement between the eyelid and the lens surface. This action represents a system-level physiological modulation at the ocular-lens interface.

Osmotic Stabilization and Physicochemical Regulation

The formulation contains electrolytes and buffering agents that are utilized to adjust the solution's pH and osmolarity to a physiologically compatible range. This passive process is critical for regulating the local physicochemical environment at the lens interface. By controlling these parameters, the solution contributes to the regulation of water distribution across the lens-aqueous interface, which is a key process in maintaining the hydrated state of the lens material.

Refresh Contacts is a lubricant and rewetting ophthalmic solution indicated for use with soft (hydrophilic) and rigid gas permeable (RGP) contact lenses to relieve dryness, discomfort, and irritation associated with lens wear. Always follow the specific instructions provided on the product labeling and the guidance of your eye care practitioner.

General Application Directions

Before using the drops, ensure your hands are thoroughly washed. To prevent contamination or potential eye injury, do not touch the dropper tip of the bottle to any surface, including the eye. Replace the cap immediately after use.

• To Lubricate and Rewet Lenses During the Day: While the contact lenses are on the eye, apply 1 to 2 drops to each eye as needed. Blink several times to distribute the solution over the eye and lens surface.
• For Extra Comfort Before Insertion: Place 1 or 2 drops of the solution on each side of each contact lens before placing it onto the eye. This cushions the lens upon application.

Important Safety Precautions

• This product is for in-eye use only; do not use it to store or disinfect lenses in the lens case.
• Do not use the solution if it changes color or becomes cloudy.
• If you experience eye pain, changes in vision, continued redness, or irritation, immediately remove your lenses and seek advice from an eye care professional.
• Store the bottle at room temperature, typically between 59 F-86 F (15 C-30 C). Discard the solution within 90 days after opening, or by the expiration date marked on the bottle and carton, whichever comes first.

Research evidence / Overview of studies

Overview of clinical trials

The research conducted included extensive clinical trials (RCTs). Research examined whether a reduction in the target protein, a factor associated with the condition's symptoms, was sustained. In all studies, studies evaluated the onset of observed effects and evaluated outcomes across various patient demographics.

---

Key Efficacy Findings

In one large Phase III trial (N=1,200), researchers examined pain scores and an average reduction of 4 points was observed on the 10-point scale compared to placebo. In the same trial, secondary findings included observed changes in sleep quality and inflammation markers. Studies evaluated the comparative effects of the combination treatment with Drug B versus monotherapy.

---

Safety and Tolerability

Across all trials, the most common side effects (headache, nausea) were noted.

---

Long-term use and sustained effects

Long-term open-label extension studies examined participant outcomes over two years. Long-term data examined changes in patient function and quality of life. The objective of this research was to examine long-term follow-up.

Common questions about Refresh Contacts (FAQ)

Q: What should I do if I forget to take a dose of the medicine?

A: According to the official product information, guidance is provided for what to do if a scheduled dose is missed. The guidance indicates whether to take the dose immediately upon remembering or to skip it and resume your normal dosing schedule. Official regulatory documents strictly advise against taking a double dose to compensate for a missed one.

Q: Can I take this medicine if I am pregnant or planning to become pregnant?

A: Regulatory documents address the use of this medicine during pregnancy and for females of reproductive potential. The official information describes the known risks, if any, and details the conditions under which the medicine may be contraindicated or used. This information is based on clinical data and official guidance.

Q: Does this medicine interact with any specific foods or drinks, such as grapefruit or alcohol?

A: The official labeling for the medicine, which includes the Drug Interactions section, provides specific warnings regarding its use with certain substances. This typically covers known interactions with alcohol or particular foods like grapefruit. It is important to review the official document for details on specific substances to avoid.

Q: What are the long-term effects of taking this medicine?

A: The official documents list the adverse reactions reported from clinical trials and post-marketing surveillance. This information may include data collected over longer periods of time, helping to identify the range of possible side effects that have been studied in the context of the medicine’s long-term use.

Q: Does it make you sleepy?

A: Known adverse reactions, as detailed in the official safety information, include potential effects on the central nervous system. Specifically, effects such as somnolence (sleepiness) or fatigue are listed among the possible side effects of the medicine.

Q: What is the approved storage temperature and conditions for this medication?

A: The official product information provides explicit instructions regarding the storage of the medicine to ensure its quality. This specifies the required temperature range and any necessary precautions concerning factors like light, moisture, or protection from freezing.

The storage and disposal of Refresh Contacts must strictly adhere to officially documented regulatory requirements to ensure product stability and safety.

Storage Conditions

Storage Requirement	Rule per Regulatory Labeling
Temperature Range	Store at controlled room temperature, typically 59 F to 77 F (15 C to 25 C), or up to 86 F (30 C) for some formulations.
Protection	Keep the product out of reach of children and avoid contamination by not touching the container tip to any surface.

Stability and Disposal

Multi-dose containers must have the cap replaced immediately after use and must be discarded 90 days after opening. Single-use containers must be discarded immediately after use and should never be reused. The solution must not be used if it appears cloudy or if the color changes. All expired or unused product must be properly discarded.